Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies.
Shallis RM, Bewersdorf JP, Swoboda DM, Wei W, Gowda L, Prebet T, Halene S, Pillai MM, Parker T, Neparidze N, Podoltsev NA, Seropian S, Sallman DA, Gore SD, Zeidan AM.
Shallis RM, et al. Among authors: neparidze n.
Clin Lymphoma Myeloma Leuk. 2021 May;21(5):e483-e487. doi: 10.1016/j.clml.2021.01.003. Epub 2021 Jan 12.
Clin Lymphoma Myeloma Leuk. 2021.
PMID: 33551344
No abstract available.